TN SB2292 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 30 2024 - 25% progression, died in committee
Action: 2024-02-01 - Passed on Second Consideration, refer to Senate Health and Welfare Committee
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #2) [PDF]
Status: Introduced on January 30 2024 - 25% progression, died in committee
Action: 2024-02-01 - Passed on Second Consideration, refer to Senate Health and Welfare Committee
Pending: Senate Health and Welfare Committee
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, changes the date, from February 15 to February 1, that an annual report on use of medication-assisted treatment for opiate addiction is due in each year after 2024. - Amends TCA Title 33; Title 38; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
AN ACT to amend Tennessee Code Annotated, Title 33; Title 38; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to buprenorphine.
Sponsors
| Sen. Rusty Crowe [R] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-01 | Senate | Passed on Second Consideration, refer to Senate Health and Welfare Committee |
| 2024-01-31 | Senate | Introduced, Passed on First Consideration |
| 2024-01-30 | Senate | Filed for introduction |
Same As/Similar To
HB2668 (Crossfiled) 2024-02-05 - P2C, caption bill, held on desk - pending amdt.
